Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Accenture
Mallinckrodt
Boehringer Ingelheim
McKinsey
Baxter
Argus Health
Dow
Cantor Fitzgerald

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 063322

« Back to Dashboard

NDA 063322 describes PENTACEF, which is a drug marketed by Glaxosmithkline and is included in three NDAs. Additional details are available on the PENTACEF profile page.

The generic ingredient in PENTACEF is ceftazidime. There are seventeen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.
Summary for 063322
Tradename:PENTACEF
Applicant:Glaxosmithkline
Ingredient:ceftazidime
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 063322

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength1GM/VIAL
Approval Date:Nov 7, 1995TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength2GM/VIAL
Approval Date:Nov 7, 1995TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
US Army
Cipla
Express Scripts
Queensland Health
Argus Health
UBS
Medtronic
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.